Patents by Inventor Xiangyang Zhu

Xiangyang Zhu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11098285
    Abstract: The present invention provides a virulent Pseudomonas fluorescens (P. fluorescens) phage ?Pf1901, and a phage ?Pf1901 preparation and an application thereof, and relates to the technical field of phage. The virulent P. fluorescens phage ?Pf1901 has an accession number of CCTCC M2019447. The virulent phage ?Pf1901 has a titer of (1.4-3)×1010 PFU/mL. The virulent phage ?Pf1901 has an optimal multiplicity of infection (MOI) value of 0.0001. The virulent P. fluorescens phage ?Pf1901 provided by the present invention exhibits very high specificity and lytic ability to P. fluorescens, which can be used to control P. fluorescens, with strong lytic and scavenging effects on a host.
    Type: Grant
    Filed: October 8, 2019
    Date of Patent: August 24, 2021
    Assignee: Bohai University
    Inventors: Jianrong Li, Defu Zhang, Qiuhua Zhu, Ming Zhang, Gang Song, Xuepeng Li, Xiangyang Yu, Peng Zhang, Qinghai Wang, Jian Zhang, Xudong Zhang, Jia Yao, Xiaohong Hu, Xuefei Liu, Fengling Bai, Tingting Li, Qiuying Li, Ying Bu, Shumin Yi, Tong Sun, Ying Liu, Tianhui Yan, Chun Chang
  • Publication number: 20210198355
    Abstract: The present invention relates to anti-IL-23p19 binding compounds, in particular new humanized anti-IL-23p19 antibodies and therapeutic and diagnostic methods and compositions for using the same.
    Type: Application
    Filed: October 9, 2020
    Publication date: July 1, 2021
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Rachel Rebecca Barrett, Keith A. Canada, Katrina Mary Catron, Robert Copenhaver, Lee Edward Frego, Ernest Lee Raymond, Sanjaya Singh, Xiangyang Zhu
  • Patent number: 10981983
    Abstract: The present invention provides an antibody targeted to interleukin 17A (IL-17A), preparation method and the use thereof. In particular, the invention provides a novel anti-IL-17A monoclonal antibody. The antibody of the present invention is capable of binding IL-17A antigen with high specificity, has high affinity and low immunogenicity, and is used for preparing a medicament for preventing or treating an IL-17A-related disease such as various inflammatory or autoimmune diseases.
    Type: Grant
    Filed: January 19, 2018
    Date of Patent: April 20, 2021
    Assignee: Huabo Biopharm (Shanghai) Co., Ltd.
    Inventors: Xiangyang Zhu, Mingqing Cai, Haijia Yu, Huifeng Jia, Ling Yu
  • Publication number: 20210079307
    Abstract: An apparatus to simulate biocide performance in crude oil pipeline conditions is disclosed. The apparatus includes: a reactor to simulate a two-phase crude oil pipeline which includes a crude oil phase above a water phase. The reactor has an agitator to control a flow of the water phase in the reactor in response to a motor that drives an agitation rate of the agitator. A crude oil inlet supplies crude oil to the reactor for the crude oil phase. A water inlet supplies water to the reactor for the water phase. A control circuit is configured by code to control a proportion of the water to the crude oil supplied to the reactor and to control the motor to drive a desired agitation rate of the agitator. A biocide inlet supplies biocide to the reactor. A water sample outlet enables sampling of the water phase of the reactor.
    Type: Application
    Filed: September 16, 2019
    Publication date: March 18, 2021
    Inventors: Xiangyang Zhu, Mazen A. Al-Saleh, Qurban Ali
  • Publication number: 20210036950
    Abstract: The embodiments of the present disclosure provide a data packet processing method and apparatus, a storage medium and an electronic device. The method includes that: a Bit Index Explicit Replication (BIER) Multicast Identifier (BMID) information of a data packet is set, wherein the BMID information is used for indicating a multicast channel to which the data packet belongs; and the BMID information is sent to a Bit-Forwarding Ingress Router (BFIR). Through the solution in the embodiments of the present disclosure, the technical problem in the related art that a node receives duplicate data packets is solved, duplicate data packets may be prevented, and data transmission efficiency is improved.
    Type: Application
    Filed: March 1, 2019
    Publication date: February 4, 2021
    Inventor: Xiangyang ZHU
  • Publication number: 20200395593
    Abstract: Methods and systems are provided for fabricating a large format lithium ion electrochemical cell that includes an anode and a cathode. In one example, the anode is prepared via loading the anode to a predetermined anode loading amount, followed by electrochemical pre-lithiation of the anode via electrically coupling an auxiliary electrode to the anode where lithium is transferred to the anode through an electrolyte solution from the auxiliary electrode. In this way, pre-lithiation of the anode may be improved, which may in turn increase a capacity of the large format lithium ion electrochemical cell.
    Type: Application
    Filed: June 12, 2020
    Publication date: December 17, 2020
    Inventors: Xiangyang Zhu, Weidong Zhou, Jun Wang, Hong Yan, Derek C. Johnson
  • Publication number: 20200071394
    Abstract: The present invention provides an antibody targeted to interleukin 17A (IL-17A), preparation method and the use thereof. In particular, the invention provides a novel anti-IL-17A monoclonal antibody. The antibody of the present invention is capable of binding IL-17A antigen with high specificity, has high affinity and low immunogenicity, and is used for preparing a medicament for preventing or treating an IL-17A-related disease such as various inflammatory or autoimmune diseases.
    Type: Application
    Filed: January 19, 2018
    Publication date: March 5, 2020
    Inventors: Xiangyang ZHU, Mingqing CAI, Haijia YU, Huifeng JIA, Ling YU
  • Patent number: 10501625
    Abstract: A method of making acrylamide-acrylic acid copolymers in water-in-oil latices is described. The method results in a copolymer having randomly distributed carboxylate functionalities and is suitable for ionic crosslinking. The copolymers and their ionically crosslinked counterparts are useful for enhanced oil recovery processes.
    Type: Grant
    Filed: June 23, 2016
    Date of Patent: December 10, 2019
    Assignee: Ecolab USA Inc.
    Inventors: Stephen Marrou, Xiangyang Zhu, Heqing Huang
  • Patent number: 10472443
    Abstract: Highly random acrylamide-acrylic acid copolymers are described. Ionic crosslinking of the highly random copolymers in dilute solution results in improved viscosity and gel strength compared to copolymers prepared by conventional methods. The ionically crosslinked copolymers are useful in enhanced oil recovery processes.
    Type: Grant
    Filed: June 23, 2016
    Date of Patent: November 12, 2019
    Assignee: Ecolab USA Inc.
    Inventors: Stephen Marrou, Xiangyang Zhu, Heqing Huang
  • Publication number: 20190144534
    Abstract: The present invention relates to anti-IL-23p19 binding compounds, in particular new humanized anti-IL-23p19 antibodies and therapeutic and diagnostic methods and compositions for using the same.
    Type: Application
    Filed: January 25, 2019
    Publication date: May 16, 2019
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Rachel Rebecca Barrett, Keith A. Canada, Katrina Mary Catron, Robert Copenhaver, Lee Edward Frego, Ernest Lee Raymond, Sanjaya Singh, Xiangyang Zhu
  • Patent number: 10202448
    Abstract: The present invention relates to anti-IL-23p19 binding compounds, in particular new humanized anti-IL-23p19 antibodies and therapeutic and diagnostic methods and compositions for using the same.
    Type: Grant
    Filed: August 4, 2016
    Date of Patent: February 12, 2019
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Rachel Rebecca Barrett, Keith A. Canada, Katrina Mary Catron, Robert Copenhaver, Lee Edward Frego, Ernest Lee Raymond, Sanjaya Singh, Xiangyang Zhu
  • Patent number: 10179855
    Abstract: A method of making acrylamide-acrylic acid copolymers in water-in-oil latices is described. The method results in a copolymer having randomly distributed carboxylate functionalities and is suitable for ionic crosslinking. The copolymers and their ionically crosslinked counterparts are useful for enhanced oil recovery processes.
    Type: Grant
    Filed: June 23, 2016
    Date of Patent: January 15, 2019
    Assignee: Ecolab USA Inc.
    Inventors: Stephen Marrou, Xiangyang Zhu, Heqing Huang
  • Publication number: 20160376389
    Abstract: Highly random acrylamide-acrylic acid copolymers are described. Ionic crosslinking of the highly random copolymers in dilute solution results in improved viscosity and gel strength compared to copolymers prepared by conventional methods. The ionically crosslinked copolymers are useful in enhanced oil recovery processes.
    Type: Application
    Filed: June 23, 2016
    Publication date: December 29, 2016
    Inventors: Stephen Marrou, Xiangyang Zhu, Heqing Huang
  • Publication number: 20160376390
    Abstract: A method of making acrylamide-acrylic acid copolymers in water-in-oil latices is described. The method results in a copolymer having randomly distributed carboxylate functionalities and is suitable for ionic crosslinking. The copolymers and their ionically crosslinked counterparts are useful for enhanced oil recovery processes.
    Type: Application
    Filed: June 23, 2016
    Publication date: December 29, 2016
    Inventors: Stephen Marrou, Xiangyang Zhu, Heqing Huang
  • Publication number: 20160333091
    Abstract: The present invention relates to anti-IL-23p19 binding compounds, in particular new humanized anti-IL-23p19 antibodies and therapeutic and diagnostic methods and compositions for using the same.
    Type: Application
    Filed: August 4, 2016
    Publication date: November 17, 2016
    Inventors: Rachel Rebecca BARRETT, Keith A. CANADA, Katrina Mary CATRON, Robert COPENHAVER, Lee Edward FREGO, Ernest Lee RAYMOND, Sanjaya SINGH, Xiangyang ZHU
  • Patent number: 9441036
    Abstract: The present invention relates to anti-IL-23p19 binding compounds, in particular new humanized anti-IL-23p19 antibodies and therapeutic and diagnostic methods and compositions for using the same.
    Type: Grant
    Filed: June 12, 2014
    Date of Patent: September 13, 2016
    Assignee: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Rachel Rebecca Barrett, Keith Canada, Katrina Mary Catron, Robert Copenhaver, Lee Edward Frego, Ernest Lee Raymond, Sanjaya Singh, Xiangyang Zhu
  • Publication number: 20140363444
    Abstract: The present invention relates to anti-IL-23p19 binding compounds, in particular new humanized anti-IL-23p19 antibodies and therapeutic and diagnostic methods and compositions for using the same.
    Type: Application
    Filed: June 12, 2014
    Publication date: December 11, 2014
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Rachel Rebecca BARRETT, Keith CANADA, Katrina Mary CATRON, Robert COPENHAVER, Lee Edward Frego, Ernest Lee Raymond, Sanjaya SINGH, Xiangyang ZHU
  • Patent number: 8778346
    Abstract: The present invention relates to anti-IL-23p19 binding compounds, in particular new humanized anti-IL-23p19 antibodies and therapeutic and diagnostic methods and compositions for using the same.
    Type: Grant
    Filed: November 2, 2011
    Date of Patent: July 15, 2014
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Rachel Rebecca Barrett, Keith Canada, Katrina Mary Catron, Robert Copenhaver, Lee Edward Frego, Ernest Lee Raymond, Sanjaya Singh, Xiangyang Zhu
  • Publication number: 20120282269
    Abstract: The present invention relates to anti-IL-23p19 binding compounds, in particular new humanized anti-IL-23p19 antibodies and therapeutic and diagnostic methods and compositions for using the same.
    Type: Application
    Filed: November 2, 2011
    Publication date: November 8, 2012
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Rachel Rebecca Barrett, Keith Canada, Katrina Mary Catron, Robert Copenhaver, Lee Edward Frego, Ernest Lee Raymond, Sanjaya Singh, Xiangyang Zhu
  • Publication number: 20120093814
    Abstract: The present invention relates to therapeutic peptides and proteins fused to a canine antibody Fc domain. Methods and compositions of using the same are described.
    Type: Application
    Filed: March 30, 2010
    Publication date: April 19, 2012
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Keith Canada, Sanjaya Singh, Xiangyang Zhu